Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Is there a health benefit of reduced tobacco consumption? A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Smoking behavior among hospital staff still influences attitudes and counseling on smoking

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Sleep Apnea, the Risk of Developing Heart Failure, and Potential Benefits of Continuous Positive Airway Pressure (CPAP) Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cerebral blood flow, oxygen metabolism, and lactate during hypoxia in patients with obstructive sleep apnea

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mortality and use of psychotropic medication in sleep apnoea patients: a population-wide register-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A Sleep Position Trainer for positional sleep apnea: a randomized, controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Obstructive sleep apnea: effect of comorbidities and positive airway pressure on all-cause mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Dianicline is a α4β2 nicotinic acetylcholine receptor partial agonist, a class of drugs that includes varenicline and cytisine. Varenicline is efficacious for smoking cessation, while cytisine has not been studied systematically. The efficacy of dianicline has not been previously tested in an adequately powered study.
Original languageEnglish
JournalNicotine & Tobacco Research
Volume13
Issue number1
Pages (from-to)1-6
Number of pages6
ISSN1462-2203
DOIs
Publication statusPublished - 1 Jan 2011

    Research areas

  • Adult, Azepines, Double-Blind Method, Female, Heterocyclic Compounds with 4 or More Rings, Humans, Male, Middle Aged, Nicotinic Agonists, Placebos, Receptors, Nicotinic, Smoking, Smoking Cessation

ID: 32785444